{
    "nctId": "NCT03589924",
    "briefTitle": "Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop\u00ae Bra(COSTA)",
    "officialTitle": "A Randomized Multicenter, Open, Prospective, Controlled Study-comparison of the Safety of Immediate One-stage Implant Based Breast Reconstruction(IBBR) Versus Two-stage Expander-Implant IBBR Augmented With TiLoop\u00ae Bra.",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 440,
    "primaryOutcomeMeasure": "Rate of perioperative complications",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with histological proven invasive breast cancer or ductal carcinoma in situ;\n* Clinical T1-T2 disease with no distant metastasis;\n* Patient with clinical N0 status;\n* Intent to receive NSM or SSM and implant based breast reconstruction;\n* Signed consent to participate.\n\nExclusion Criteria:\n\n* Patient with severe breast ptosis;\n* Patient received ipsilateral breast reduction or enlargement;\n* Locally advanced stage patients who received neoadjuvant chemotherapy or hormone therapy;\n* Patients enrolled in other clinical trial which may as influence the outcome;\n* Patients received neo-adjuvant therapy and will receive radiotherapy.\n* History of breast cancer (ipsilateral, i.e. recurrence, or contralateral breast);\n* Patients of pregnancy or lactation.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}